NewMed Energy - Limited Partnership (DKDRF)
OTCMKTS
· Delayed Price · Currency is USD
3.350
+0.032 (0.96%)
At close: Apr 8, 2025
DKDRF Revenue
In the year 2024, NewMed Energy - Limited Partnership had annual revenue of $973.10M with 4.12% growth. NewMed Energy - Limited Partnership had revenue of $226.70M in the quarter ending December 31, 2024.
Revenue
973.10M
Revenue Growth
+4.12%
P/S Ratio
4.50
Revenue / Employee
42.31M
Employees
23
Market Cap
4.38B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 973.10M | 38.50M | 4.12% |
Dec 31, 2023 | 934.60M | -37.30M | -3.84% |
Dec 31, 2022 | 971.90M | 218.10M | 28.93% |
Dec 31, 2021 | 753.80M | 253.00M | 50.52% |
Dec 31, 2020 | 500.80M | 497.58M | 15,467.30% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Cyber App Solutions | 586.70K |
EXCO Resources | 394.03M |
Unit Corporation | 237.61M |
Pardee Resources Company | 50.63M |
Vantage Drilling International | 204.51M |
Granite Falls Energy, LLC | 409.95M |
Empire Diversified Energy | 3.64M |
Ferrellgas Partners | 1.89B |
NewMed Energy - Limited Partnership News
- 5 months ago - Why Investors Should Consider NewMed Energy (Rating Upgrade) - Seeking Alpha
- 6 months ago - High Yield Oil And Gas Ranked By Relative Quality - Seeking Alpha
- 2 years ago - VR Capital Reiterates Intention to Vote AGAINST Proposed Business Combination Between Capricorn Energy and NewMed Energy and IN FAVOUR of Palliser Capital's Proposed Changes to Composition of the Company Board - PRNewsWire
- 2 years ago - EXCLUSIVE Hedge fund Irenic asks Capricorn Energy to ditch NewMed deal - Reuters